Can I Take the Pill With the Implant to Stop Bleeding?

Taking the combined oral contraceptive pill alongside the contraceptive implant is a recognized, off-label strategy that clinicians commonly use to manage irregular or prolonged bleeding. Randomized trials show it works for most people in the short term, with roughly nine out of ten implant users reporting meaningful improvement in bleeding while on the pill. The catch is that the effect tends to be temporary, with bleeding often returning once the pill course ends, and the evidence for the best duration of treatment, or whether repeated courses are wise, remains thin.

What the Trials Actually Show

Two small randomized controlled trials have directly tested combined oral contraceptives against placebo in implant users experiencing bothersome bleeding. In one, participants took a standard combined pill for 14 days. About 88% of those on the pill had a temporary interruption of their bleeding during treatment, compared with about 38% of those on placebo. The difference was large and statistically clear.¹ In a second trial, all women randomized to combined pills reported improvement at four weeks, and about 92% described the improvement as significant, compared with 42% of those given placebo.²

Those numbers sound encouraging, but both trials were small, each enrolling only a few dozen participants. The evidence is consistent enough that many clinicians feel comfortable recommending the approach, yet large-scale data confirming an ideal pill brand, dose, or treatment length are still missing.

The Rebound Problem

The most frustrating part of this approach is what happens after you stop the pill. In the 14-day trial, roughly 86% of the women whose bleeding had stopped during pill treatment saw it return within ten days of finishing the course.¹ So the pill is more of a pause button than a cure. It can buy you a stretch of lighter or no bleeding, which is useful for holidays, exams, or simply getting a break, but it does not usually reset the bleeding pattern permanently.

Some clinicians prescribe the pill continuously (skipping the placebo row) for weeks or even a few months on top of the implant, hoping to stabilize the endometrial lining long enough that the bleeding does not return as aggressively. This makes biological sense because the implant thins and destabilizes the uterine lining through constant progestogen exposure, and estrogen in the pill helps support the blood vessels in that lining and reduce breakthrough bleeding. The fragile, dilated vessels that progestogen-only methods create in the endometrium are thought to be the root of the irregular bleeding, and estrogen can shore those vessels up temporarily.³ But there are no large trials testing whether continuous pill use on top of the implant for months at a time is safe or more effective than a short course. It is an extrapolation from the short-term data, and your clinician will weigh the risks, particularly around blood clots, on a case-by-case basis.

Does Adding the Pill Reduce Implant Effectiveness?

This is a worry that comes up often, and the short answer is reassuring. The contraceptive implant works primarily by suppressing ovulation and thickening cervical mucus, and adding a combined pill does not interfere with either mechanism. In fact, the combined pill suppresses ovulation through its own pathways, so in theory you end up with two overlapping layers of contraceptive protection. There is no evidence from the available trials that using both methods together leads to higher pregnancy rates.

The concern about contraceptive efficacy is more relevant with experimental drugs. A study of mifepristone (a progesterone receptor blocker), given either alone or with ethinyl estradiol to stop implant-related bleeding, found that while the drug effectively halted bleeding episodes, it could impair the implant’s contraceptive action by allowing ovulation to resume.⁴ That is a very different situation from adding a standard combined pill, but it illustrates why it matters which medication you layer on top of the implant.

What Else Can Help Besides the Pill

If you would rather not add estrogen, or if you have a reason you cannot take it (a history of migraine with aura, for example, or a clotting disorder), there are other options worth discussing with your provider. None is a slam dunk, and the evidence behind each one varies.

Mefenamic Acid and Other Anti-Inflammatories

Mefenamic acid, a prescription anti-inflammatory related to ibuprofen, has some of the better evidence for implant-related bleeding. In a study of implant users (using the older Norplant system), about 76% of women taking mefenamic acid had their bleeding stop during the first week of treatment, compared with 27% on placebo. Over the following four weeks, the mefenamic acid group also had fewer bleeding and spotting days.⁵ A recent systematic review confirmed that mefenamic acid and celecoxib generally showed improved bleeding patterns during and after treatment compared to placebo.⁶

Ibuprofen, which is easier to get over the counter, is a different story. A trial comparing ethinyl estradiol, ibuprofen, and placebo in implant users found no difference in bleeding duration among the three groups, though estrogen did slightly reduce spotting days.⁷ The same systematic review found that ibuprofen trials showed no improvements during treatment and inconsistent results afterward.⁶ So reaching for generic ibuprofen at home is unlikely to make a meaningful difference, even though it seems like the logical first thing to try.

Tranexamic Acid

Tranexamic acid is a medication that slows down blood clot breakdown and is widely used for heavy menstrual bleeding unrelated to implants. Because of that track record, it seemed like a promising option. Unfortunately, a randomized trial specifically testing a five-day course of tranexamic acid in implant users experiencing frequent or prolonged bleeding found that it did not improve bleeding patterns.⁸ The mechanism of implant bleeding appears different enough from typical heavy periods that what works for one does not necessarily work for the other.

Understanding the Bleeding Pattern Itself

Before adding any medication, it helps to know what is normal with the implant. A study tracking bleeding patterns in implant users found that about 22% had no periods at all, about 34% had infrequent bleeding, roughly 18% had prolonged bleeding, and about 7% had frequent bleeding.⁹ In three-quarters of reference periods, the total number of bleeding and spotting days was actually fewer than or comparable to a natural cycle, but the timing was unpredictable, which is what bothers people most.

Perhaps the most useful finding from that study: the bleeding pattern you experience in the first three months tends to predict what happens later. Women who had a favorable pattern early on generally kept it, while those with unfavorable early patterns had at least a 50% chance of improvement over time.⁹ So if you are in your first few months and the bleeding is difficult, there is a genuine chance it will settle on its own. That is exactly the window where a short pill course can serve as a bridge, giving you relief while you wait to see if your body adjusts.

Why Treating Bleeding Matters for Keeping the Implant

Bleeding irregularity is the number-one reason people have their implant removed early. Research on older implant systems found that removal rates were dramatically higher in women reporting menstrual complaints compared to those who did not, and bleeding problems were the most important factor limiting implant acceptability.¹⁰ A more recent study of adolescents using the current etonogestrel implant found that those who received some form of treatment for bothersome bleeding were significantly more likely to keep their implant for at least a year: about 67% retained it versus 40% of those who received no treatment.¹¹

That gap is striking and suggests that even an imperfect, temporary fix like a short pill course can make the difference between someone sticking with a highly effective contraceptive and abandoning it. The implant has a failure rate well below one percent per year, so anything that helps people tolerate its side effects long enough to benefit from that protection has real public health value.

Safety Considerations When Combining Methods

The implant is a progestogen-only method, and the combined pill adds estrogen. Estrogen is what carries the clotting-related risks that some people need to avoid. If you are eligible to take a combined pill on its own, you can generally take one alongside your implant without additional worry. The main categories of people who should not add estrogen include those with a history of blood clots, certain types of migraine, uncontrolled high blood pressure, or a strong family history of clotting disorders. Your provider will apply the same eligibility criteria they would use if you were considering the pill as your sole contraceptive.

For a short course of one to three months, the absolute risk increase from estrogen is very small in otherwise healthy people. The concern grows with longer use, which is another reason clinicians tend to prescribe the pill as a short-term intervention on top of the implant rather than an indefinite add-on. If you find yourself needing to restart the pill every time a course ends, it is worth having a conversation about whether the implant is the right method for you rather than committing to years of dual hormonal exposure.

Iron and Longer-Term Health

Prolonged or frequent bleeding can gradually deplete your iron stores, even if each individual episode seems light. One large analysis found that users of hormonal contraceptive methods, including implants, generally had higher hemoglobin and ferritin levels than non-users, with differences of roughly 3 to 6 grams per liter for hemoglobin and 2 to 18 grams per liter for ferritin.¹² That finding reflects the overall population of hormonal contraceptive users, many of whom bleed less than they did on no method at all. But the subset who experience prolonged or frequent implant bleeding can end up in the opposite situation, losing more blood than they would during natural cycles.

If you are in that subset, it is worth asking your provider to check your iron levels, especially if you feel unusually tired, short of breath during exercise, or lightheaded. An iron supplement is cheap and safe for most people and can prevent a slide into anemia while you figure out whether the bleeding will settle or whether you want to try a treatment course.

What About Just Waiting It Out?

Patience is genuinely a valid strategy for some people, and the data backs this up. Since at least half of those with unfavorable bleeding in the first three months see improvement over time, simply waiting (with counseling about what to expect) can work.⁹ The challenge is that “wait and see” is cold comfort when you have been spotting for three weeks straight and have a drawer full of ruined underwear. This is where a short pill course can be framed not as a permanent fix but as a bridge: it stops the bleeding now, and when you come off the pill, you are a few weeks further into the implant’s life and the body may have adjusted.

If you are past the first year and the bleeding has not improved, the odds of spontaneous resolution drop. At that point, the conversation shifts toward whether medical treatment (pill, mefenamic acid) is worth repeating, whether a different method would suit you better, or whether you are willing to tolerate the pattern in exchange for the implant’s other benefits.

Practical Tips if You and Your Provider Decide to Try the Pill

There is no standardized protocol for this, but common approaches based on the available trials and clinical experience include:

Duration: A 14-day course of a monophasic combined pill is what the best-designed trial used. Some providers prescribe 21 or 28 days, or even continuous use for up to three months, depending on how you respond.
Timing: Starting the pill when you are actively bleeding, rather than during a break, tends to make more sense because the goal is to stop the current episode.
Pill choice: A standard monophasic pill with 30 to 35 micrograms of ethinyl estradiol is typical. There is no trial evidence favoring one brand over another for this use.
Repeat courses: If bleeding returns after the first course, many providers will offer one or two more short courses. If the pattern persists through multiple attempts, it is a signal to reconsider the overall plan.

Keep a simple log of your bleeding days during and after the pill course. It does not need to be elaborate: a calendar where you mark bleeding, spotting, and nothing is enough. Having that record when you follow up makes it much easier for your provider to judge whether the treatment helped and what to try next.

Treatments That Sound Promising but Lack Evidence

You will find recommendations online for vitamin E, evening primrose oil, and various herbal remedies for implant bleeding. None of these have been tested in rigorous trials of implant users, and there is no pharmacological reason to expect them to stabilize the fragile endometrial vasculature that progestogen-only methods create. They are unlikely to cause harm, but spending weeks on an unproven supplement while bleeding persists delays interventions that actually have data behind them.

Tamoxifen and ulipristal acetate have shown some promise in small studies, with the systematic review noting generally improved bleeding patterns compared to placebo.⁶ However, both carry their own side effect profiles and are not routinely prescribed for this purpose. Mifepristone, as noted earlier, raises concerns about undermining the implant’s contraceptive action.⁴ For now, the combined pill and mefenamic acid remain the two options with the most favorable balance of evidence, availability, and safety for everyday clinical use.